Senior Director, Regional Facilities Operations & EHS at Bristol-Myers Squibb

Princeton, New Jersey, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, BiotechnologyIndustries

Requirements

Lead a high-performing EHS and Facilities Operations team utilizing an Integrated Facility Management (IFM) model
Accountability for safe, compliant, and efficient operation of assigned BMS sites across Central New Jersey (facilities 500,000 to 3.5 million square feet, including R&D, PD and QC laboratories, CTO manufacturing, office spaces, and site amenities)
Full accountability for an operating budget exceeding $100 million
Collaborate with senior leaders across Manufacturing, Product Development, EHS, Cell Therapy, R&D, and Real Estate to develop and execute regional site and space strategies
Collaborate with Capital Project Engineering to deliver the region’s capital plan
Model exemplary EHS behaviors
Cultivate strong communication with stakeholders
Lead EHS and Facilities Operations teams through change with agility and operational excellence
Full-time, on-site position requiring regular presence in the region
Key member of the Global Facilities Operations (GFO) leadership team

Responsibilities

Develop and execute comprehensive regional site and space strategies that align with BMS business objectives
Engage with senior leadership across Manufacturing, Product Development, EHS, Cell Therapy, R&D, and Real Estate to ensure site operations are integrated into strategic business priorities
Act as an ambassador for the region to foster strong relationships with local communities and authorities, delivering timely communication and a positive corporate presence in adherence to local regulatory requirements
Collaborate with key stakeholders to drive the success of the Integrated Facility Management (IFM) strategy, optimizing space utilization, enhancing operational efficiencies, and driving innovation to support the company’s long-term growth and operations

Skills

EHS

Facilities Operations

Integrated Facility Management

IFM

Operations Management

Contract Management

Vendor Management

Asset Management

Document Management

Sustainability

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free